FDA investigators audited the Gemini Pharmaceuticals - Commack, NY, United States facility and issued 2 inspectional observations (via FDA 483) on 23 Mar 2010.
Product details
- Category: Animal Drugs & Feeds / Human Drugs
- Number of Observations: 2
- Inspection end: 23 Mar 2010
- Location: Commack, United States
- FEI: 2432926
